Back
4D Molecular Therapeutics, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
14
FDMT
4D Molecular Therapeutics, Inc.
Last Price:
$7.88
Seasonality Move:
0.56%
Buy
51
BXC
BlueLinx Holdings, Inc.
Last Price:
$61.33
Seasonality Move:
23.8%
Sell
14
4D Molecular Therapeutics, Inc. (FDMT)
is a Sell
Is 4D Molecular Therapeutics, Inc. a Buy, Sell or Hold?
-
The current 4D Molecular Therapeutics, Inc. [FDMT] share price is $8.71. The Score for FDMT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
51
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $60.87. The Score for BXC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics, Inc.'s stock price today?
-
The 4D Molecular Therapeutics, Inc. share price today is $8.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $60.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 37.3 | Sell |
| Chaikin Money Flow: | -268205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.69 - 11.31) | Sell |
| Bollinger Bands (100): | (6.92 - 10.86) | Sell |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 45.8 | Sell |
| Chaikin Money Flow: | -57962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.91 - 64.47) | Buy |
| Bollinger Bands (100): | (61.87 - 78.87) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.94 | Sell |
| 20-day SMA: | 10.47 | Sell |
| 50-day SMA: | 10.63 | Sell |
| 200-day SMA: | 6.32 | Buy |
| 8-day EMA: | 9.59 | Sell |
| 20-day EMA: | 10.18 | Sell |
| 50-day EMA: | 10.04 | Sell |
| 200-day EMA: | 8.26 | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.89 | Sell |
| 20-day SMA: | 62.24 | Sell |
| 50-day SMA: | 63.61 | Sell |
| 200-day SMA: | 72.07 | Sell |
| 8-day EMA: | 62.87 | Sell |
| 20-day EMA: | 62.39 | Sell |
| 50-day EMA: | 64.25 | Sell |
| 200-day EMA: | 74.6 | Sell |
4D Molecular Therapeutics, Inc. Earnings Growth & FDMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
4D Molecular Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||